CN110584796A - Tissue marking needle - Google Patents
Tissue marking needle Download PDFInfo
- Publication number
- CN110584796A CN110584796A CN201910916450.8A CN201910916450A CN110584796A CN 110584796 A CN110584796 A CN 110584796A CN 201910916450 A CN201910916450 A CN 201910916450A CN 110584796 A CN110584796 A CN 110584796A
- Authority
- CN
- China
- Prior art keywords
- tissue
- marking needle
- poly
- base
- tissue marking
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000011248 coating agent Substances 0.000 claims abstract description 26
- 238000000576 coating method Methods 0.000 claims abstract description 26
- 239000000463 material Substances 0.000 claims description 26
- 229920000747 poly(lactic acid) Polymers 0.000 claims description 8
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 claims description 8
- 229920002463 poly(p-dioxanone) polymer Polymers 0.000 claims description 8
- 239000000622 polydioxanone Substances 0.000 claims description 8
- 229920001577 copolymer Polymers 0.000 claims description 6
- 101100021395 Arabidopsis thaliana LIP1 gene Proteins 0.000 claims description 4
- 229920001244 Poly(D,L-lactide) Polymers 0.000 claims description 4
- 229920002732 Polyanhydride Polymers 0.000 claims description 4
- 229920001710 Polyorthoester Polymers 0.000 claims description 4
- 229920001432 poly(L-lactide) Polymers 0.000 claims description 4
- 229920002643 polyglutamic acid Polymers 0.000 claims description 4
- 229920002187 poly[N-2-(hydroxypropyl) methacrylamide] polymer Polymers 0.000 claims description 3
- 229920000724 poly(L-arginine) polymer Polymers 0.000 claims description 2
- 108010011110 polyarginine Proteins 0.000 claims description 2
- 238000001574 biopsy Methods 0.000 abstract description 25
- 210000001519 tissue Anatomy 0.000 description 91
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 16
- 239000003550 marker Substances 0.000 description 8
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 8
- 229960004889 salicylic acid Drugs 0.000 description 8
- 108010010803 Gelatin Proteins 0.000 description 6
- 206010028980 Neoplasm Diseases 0.000 description 6
- 229920000159 gelatin Polymers 0.000 description 6
- 239000008273 gelatin Substances 0.000 description 6
- 235000019322 gelatine Nutrition 0.000 description 6
- 235000011852 gelatine desserts Nutrition 0.000 description 6
- 238000001356 surgical procedure Methods 0.000 description 6
- 238000000034 method Methods 0.000 description 4
- 210000003722 extracellular fluid Anatomy 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 230000005856 abnormality Effects 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 238000002583 angiography Methods 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000002285 radioactive effect Effects 0.000 description 2
- 238000002271 resection Methods 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 150000008064 anhydrides Chemical class 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- FQPSGWSUVKBHSU-UHFFFAOYSA-N methacrylamide Chemical compound CC(=C)C(N)=O FQPSGWSUVKBHSU-UHFFFAOYSA-N 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000012857 radioactive material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/39—Markers, e.g. radio-opaque or breast lesions markers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/39—Markers, e.g. radio-opaque or breast lesions markers
- A61B2090/3937—Visible markers
- A61B2090/3941—Photoluminescent markers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/39—Markers, e.g. radio-opaque or breast lesions markers
- A61B2090/3991—Markers, e.g. radio-opaque or breast lesions markers having specific anchoring means to fixate the marker to the tissue, e.g. hooks
Landscapes
- Health & Medical Sciences (AREA)
- Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Pathology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
本发明的实施例提供了一种组织标记针,该组织标记针包括基座和钩体,其中基座上设置有发光涂层,钩体设置与基座外,将基座与需要标记的组织相连,使用时,通过肠镜的活检孔道,即可便捷地将组织标记针施放到需要标记的组织上,降低了外科医生的操作难度,也减少了患者的痛苦。An embodiment of the present invention provides a tissue marking needle, which comprises a base and a hook body, wherein the base is provided with a luminescent coating, the hook body is arranged outside the base, and connects the base to the tissue to be marked. When in use, the tissue marking needle can be conveniently placed on the tissue to be marked through the biopsy channel of the colonoscope, which reduces the difficulty of the operation for the surgeon and reduces the pain of the patient.
Description
技术领域technical field
本发明属于组织标记技术领域,具体涉及组织标记针。The invention belongs to the technical field of tissue marking, and in particular relates to a tissue marking needle.
背景技术Background technique
随着造影术筛查项目的日益流行,多数肿瘤被检测为小的、不可触诊或浅隐性的病灶。这类肿瘤的准确定位是允许外科手术去除具有充分边缘的全部肿瘤的关键。如果肿瘤未被全部切除,则患者需要经受另外的外科手术以去除任何剩余的癌组织。准确定位还有助于避免切除过多的正常组织。With the increasing popularity of screening angiography programs, most tumors are detected as small, nonpalpable, or shallowly occult lesions. Accurate localization of such tumors is critical to allow surgical removal of the entire tumor with adequate margins. If not all of the tumor is removed, the patient will need to undergo additional surgery to remove any remaining cancerous tissue. Accurate positioning also helps avoid resection of excess normal tissue.
通过常规或筛查造影术可以检查出不可触诊的病灶或异常。如果该异常是不可触诊的,则在诊断过程中,通常使用真空辅助活检(VAB)针或芯活检针进行组织活检。活检后,放置初始组织标记物,使得在后续过程期间可定位该部位。分析活检样本后,如果样本为良性,则将组织标记物长期保留在患者体内;如果活检显示出癌肿瘤,则对患者进行外科手术以去除肿瘤。Nonpalpable lesions or abnormalities can be detected by routine or screening angiography. If the abnormality is not palpable, during diagnosis, a tissue biopsy is usually performed using a vacuum-assisted biopsy (VAB) needle or a core biopsy needle. After the biopsy, initial tissue markers are placed so that the site can be located during subsequent procedures. After the biopsy sample is analyzed, if the sample is benign, the tissue markers are kept in the patient long-term; if the biopsy reveals a cancerous tumor, the patient is surgically removed to remove the tumor.
现有的组织标记方法存在以下问题:可能会引入放射性材料,一些放射性同位素具有短半衰期,限制了给药和外科手术之间的时间;需要将两种类型的标记物放置在外科手术部位,首先在活检后要放置组织标记物以标记活检部位。随后还需将另外的标记工具如放射性示踪剂或者放射性颗粒放置在相同的部位,这种重复的操作增加了外科手术团队和放射科团队的工作,也给患者增加了痛苦和风险。Existing methods of tissue labeling suffer from the following problems: possible introduction of radioactive materials, some radioisotopes have short half-lives, limiting the time between drug administration and surgery; two types of markers need to be placed at the surgical site, first Tissue markers are placed after the biopsy to mark the biopsy site. Additional marking tools such as radiotracers or radioactive particles need to be placed at the same site later. This repeated operation increases the work of the surgical team and the radiology team, and also increases pain and risk for the patient.
综上,仍需一种新的组织标记物。In summary, a new tissue marker is still needed.
发明内容Contents of the invention
为解决现有技术中,用于手术中的组织标记物所存在的问题,本发明实施例通过提供一种组织标记针,该组织标记针包括基座和钩体,其中基座上设置有发光涂层,钩体设置与基座外,将基座与需要标记的组织相连,使用时,通过肠镜的活检孔道,即可便捷地将组织标记针施放到需要标记的组织上,降低了外科医生的操作难度,也减少了患者的痛苦。In order to solve the problems existing in the tissue markers used in surgery in the prior art, the embodiment of the present invention provides a tissue marking needle, which includes a base and a hook body, wherein the base is provided with a light-emitting Coating, the hook body is set outside the base, and the base is connected with the tissue to be marked. When in use, the tissue marking needle can be conveniently placed on the tissue to be marked through the biopsy channel of the colonoscope, reducing the need for surgery. The operation difficulty of the doctor also reduces the pain of the patient.
本发明的实施例之一采用以下技术方案:One of the embodiments of the present invention adopts the following technical solutions:
组织标记针,包括Tissue marker needles, including
基座,所述基座上设置有发光涂层;a base, the base is provided with a luminescent coating;
钩体,所述钩体设置于所述基座外、与所述基座固定连接。The hook body is arranged outside the base and fixedly connected with the base.
本发明实施例的组织标记针,基座上设置有发光涂层,一方面起到标记的作用,可以准确地定位标记活检的组织部位;另一方面也方便再次找到标记处。钩体可以刺入组织中,用于将基座固定在组织上。使用时,通过肠镜的活检孔道,即可便捷地将组织标记针施放到需要标记的组织上,降低了外科医生的操作难度,也减少了患者的痛苦。In the tissue marking needle of the embodiment of the present invention, the base is provided with a luminescent coating, which on the one hand plays the role of marking, and can accurately locate and mark the tissue part of the biopsy; on the other hand, it is also convenient to find the mark again. The hook body can penetrate into the tissue and is used to fix the base on the tissue. When in use, the tissue marking needle can be conveniently placed on the tissue to be marked through the biopsy channel of the colonoscope, which reduces the difficulty of operation for the surgeon and reduces the pain of the patient.
优选地,所述组织标记针的材料为可降解材料。Preferably, the material of the tissue marking needle is a degradable material.
组织标记针的材料为可降解材料,使组织标记针可以在体内完全降解,无须为了将组织标记针从体内取出而再次实施手术。解决了现有技术中,需要通过再次手术将标记物取出的问题。The material of the tissue marking needle is a degradable material, so that the tissue marking needle can be completely degraded in the body, and there is no need to perform an operation again in order to take the tissue marking needle out of the body. It solves the problem in the prior art that the marker needs to be taken out through reoperation.
进一步优选地,所述可降解材料包括聚丙交酯(PLA)、聚(丙交酯-共-乙交酯)(PLGA)、聚酐、聚原酸酯、聚(N-(2-羟丙基)甲基丙烯酰胺)、聚(dl-丙交酯)(DLPLA)、聚(l-丙交酯)(LPLA)、聚乙交酯(PGA)、聚二氧杂环己酮(PDO)、聚(乙交酯-共-三亚甲基碳酸酯)(PGA-TMC)。Further preferably, the degradable materials include polylactide (PLA), poly(lactide-co-glycolide) (PLGA), polyanhydrides, polyorthoesters, poly(N-(2-hydroxypropyl base) methacrylamide), poly(dl-lactide) (DLPLA), poly(l-lactide) (LPLA), polyglycolide (PGA), polydioxanone (PDO) , poly(glycolide-co-trimethylene carbonate) (PGA-TMC).
更进一步优选地,所述可降解材料还包括聚(l-丙交酯-共-乙交酯)(PGA-LPLA)、聚(dl-丙交酯-共-乙交酯)(PGA-DLPLA)、聚(l-丙交酯-共-dl-丙交酯)(LPLA-DLPLA)、聚(乙交酯-共-三亚甲基碳酸酯-共-二氧杂环己酮)(PDO-PGA-TMC)和聚精氨酸中的一种或几种的共聚物。Still further preferably, the degradable material also includes poly(l-lactide-co-glycolide) (PGA-LPLA), poly(dl-lactide-co-glycolide) (PGA-DLPLA ), poly(l-lactide-co-dl-lactide) (LPLA-DLPLA), poly(glycolide-co-trimethylene carbonate-co-dioxanone) (PDO- One or more copolymers of PGA-TMC) and polyarginine.
上述可降解材料能在体内降解,安全无毒害。The above-mentioned degradable materials can be degraded in the body, and are safe and non-toxic.
优选地,所述基座(10)的形状为圆柱体,所述钩体固定设置于所述圆柱体的侧面上。Preferably, the shape of the base (10) is a cylinder, and the hook is fixedly arranged on the side of the cylinder.
钩体固定设置于所述圆柱体的侧面上,便于将组织标记针固定到需要标记的组织上。The hook body is fixedly arranged on the side of the cylinder, which is convenient for fixing the tissue marking needle to the tissue to be marked.
优选地,所述圆柱体的上底面和/或下底面为子弹头形。Preferably, the upper bottom surface and/or the lower bottom surface of the cylinder is bullet-shaped.
子弹头形的设计,便于组织标记针在肠镜活检孔道中的推进。The bullet-shaped design facilitates the advancement of the tissue marking needle in the biopsy channel of the colonoscope.
优选地,所述发光涂层为聚((二(对-羧酸苯基)丁二酸酯-共一癸二酸酸酐)(P(p-dCPS:SA))涂层。Preferably, the luminescent coating is a poly((bis(p-carboxyphenyl)succinate-comonosebacic anhydride) (P(p-dCPS:SA)) coating.
上述发光涂层,可以通过调节不同的水杨酸(SA)比例,将涂层的降解速率控制在几天到几个月之间。The above-mentioned luminescent coating can control the degradation rate of the coating between several days to several months by adjusting different salicylic acid (SA) ratios.
上述发光涂层,在紫外光(330~400nm)激发下可以发出蓝色的荧光,在可见光(450~490nm)激发下,可以发出绿色的荧光。The above luminescent coating can emit blue fluorescence when excited by ultraviolet light (330-400nm), and emit green fluorescence when excited by visible light (450-490nm).
发光涂层使得组织标记针能够被迅速识别找到。The luminescent coating enables the tissue marking pins to be quickly identified.
优选地,所述钩体的数量至少为3个。Preferably, the number of said hook bodies is at least 3.
钩体的数量为3个时,3个钩体平均分布在基座外,使组织标记针整体呈鼎状结构,可以将基座牢固地固定在组织上。When the number of hook bodies is 3, the 3 hook bodies are evenly distributed outside the base, so that the tissue marking needle has a tripod-shaped structure as a whole, and the base can be firmly fixed on the tissue.
进一步优选地,所述钩体包括第一钩体(110)、第二钩体(120)和第三钩体(130)。Further preferably, the hook body includes a first hook body (110), a second hook body (120) and a third hook body (130).
更进一步优选地,所述第一钩体(110)上设置有第一倒钩(1110),所述第二钩体(120)上设置有第二倒钩(1210),所述第三钩体(130)上设置有第三倒钩(1310)。Further preferably, the first hook body (110) is provided with a first barb (1110), the second hook body (120) is provided with a second barb (1210), and the third hook A third barb (1310) is disposed on the body (130).
倒钩的设置,进一步加强了组织标记针被固定在组织上的稳定性。The setting of the barb further strengthens the stability that the tissue marking needle is fixed on the tissue.
优选地,钩体材料为吸水膨胀材料。Preferably, the hook body material is water-swellable material.
进一步优选地,钩体材料为明胶。Further preferably, the hook body material is gelatin.
明胶在遇水或组织液后会发生膨胀,钩体变大后使基座与组织的连接更加牢固。Gelatin will swell when exposed to water or interstitial fluid, and the enlarged hook body will make the connection between the base and the tissue more firm.
优选地,所述钩体包括直钩和弯钩。Preferably, the hook body includes a straight hook and a curved hook.
钩体为直钩,便于组织标记针的推进和施放,。The hook body is a straight hook, which is convenient for advancing and releasing the tissue marking needle.
钩体为弯钩,便于使基座与组织的连接更加稳定。The hook body is a curved hook, which facilitates a more stable connection between the base and the tissue.
本发明实施例的有益效果Beneficial effects of the embodiments of the present invention
1、本发明实施例提供了一种组织标记针,该组织标记针包括基座和钩体,其中基座上设置有发光涂层,钩体设置与基座外,将基座与需要标记的组织相连,使用时,通过肠镜的活检孔道,即可便捷地将组织标记针施放到需要标记的组织上,降低了外科医生的操作难度,也减少了患者的痛苦;1. The embodiment of the present invention provides a tissue marking needle. The tissue marking needle includes a base and a hook body, wherein the base is provided with a luminous coating, and the hook body is arranged outside the base. The tissue is connected, and when in use, the tissue marking needle can be conveniently placed on the tissue to be marked through the biopsy channel of the colonoscope, which reduces the difficulty of the operation of the surgeon and the pain of the patient;
2、本发明实施例的组织标记针,材料为可降解材料,使组织标记针可以在体内完全降解,无须为了将组织标记针从体内取出而再次实施手术,解决了现有技术中,需要通过再次手术将标记物取出的问题;2. The material of the tissue marking needle in the embodiment of the present invention is a degradable material, so that the tissue marking needle can be completely degraded in the body, and there is no need to perform surgery again in order to take the tissue marking needle out of the body, which solves the problem in the prior art. Reoperation to remove the markers;
3、本发明实施例的组织标记针,基座表面设置有发光涂层,发光涂层为聚((二(对-羧酸苯基)丁二酸酯-共一癸二酸酸酐)(P(p-dCPS:SA))涂层,可以通过调节不同的水杨酸(SA)比例,将涂层的降解速率控制在几天到几个月之间,在紫外光(330~400nm)激发下可以发出蓝色的荧光,在可见光(450~490nm)激发下,可以发出绿色的荧光,能够使组织标记针迅速被识别找到,解决了现有技术中,活检放置组织标记物以后,随后还需将另外的标记工具如放射性示踪剂或者放射性颗粒放置在相同的部位,重复操作增加外科手术团队和放射科团队工作的问题。3. In the tissue marking needle of the embodiment of the present invention, the surface of the base is provided with a luminescent coating, and the luminescent coating is poly((bis(p-carboxyphenyl)succinate-co-sebacic anhydride)(P (p-dCPS: SA)) coating, the degradation rate of the coating can be controlled between a few days and a few months by adjusting different salicylic acid (SA) ratios, and excited by ultraviolet light (330-400nm) It can emit blue fluorescence under the excitation of visible light (450-490nm), and can emit green fluorescence, so that the tissue marker needle can be quickly identified and found, which solves the problem in the prior art. Additional marking tools such as radiotracers or radioactive particles need to be placed at the same site, and repeated operations add to the problems of the surgical and radiological teams.
附图说明Description of drawings
图1是实施例1组织标记针的示意图。Fig. 1 is a schematic diagram of the tissue marking needle in embodiment 1.
图2是实施例2组织标记针的示意图。Fig. 2 is a schematic diagram of the tissue marking needle in embodiment 2.
具体实施方式Detailed ways
以下是本发明的具体实施例,并结合实施例对本发明的技术方案作进一步的描述,但本发明并不限于这些实施例。The following are specific examples of the present invention, and further describe the technical solutions of the present invention in conjunction with the examples, but the present invention is not limited to these examples.
实施例1Example 1
本例提供了一种组织标记针,如图1所示,该组织标记针包括This example provides a tissue marking needle, as shown in Figure 1, the tissue marking needle includes
基座10,所述基座10上设置有发光涂层;A base 10, the base 10 is provided with a luminous coating;
钩体,所述钩体设置于所述基座10外、与所述基座10固定连接。The hook body, the hook body is arranged outside the base 10 and fixedly connected with the base 10 .
本发明实施例的组织标记针,基座上设置有发光涂层,一方面起到标记的作用,可以准确地定位标记活检的组织部位;另一方面也方便再次找到标记处。钩体可以刺入组织中,用于将基座固定在组织上。使用时,通过肠镜的活检孔道,即可便捷地将组织标记针施放到需要标记的组织上,降低了外科医生的操作难度,也减少了患者的痛苦。In the tissue marking needle of the embodiment of the present invention, the base is provided with a luminescent coating, which on the one hand plays the role of marking, and can accurately locate and mark the tissue part of the biopsy; on the other hand, it is also convenient to find the mark again. The hook body can penetrate into the tissue and is used to fix the base on the tissue. When in use, the tissue marking needle can be conveniently placed on the tissue to be marked through the biopsy channel of the colonoscope, which reduces the difficulty of operation for the surgeon and reduces the pain of the patient.
组织标记针的材料为可降解材料,使组织标记针可以在体内完全降解,无须为了将组织标记针从体内取出而再次实施手术。解决了现有技术中,需要通过再次手术将标记物取出的问题。可降解材料包括聚丙交酯(PLA)、聚(丙交酯-共-乙交酯)(PLGA)、聚酐、聚原酸酯、聚(N-(2-羟丙基)甲基丙烯酰胺)、聚(dl-丙交酯)(DLPLA)、聚(l-丙交酯)(LPLA)、聚乙交酯(PGA)、聚二氧杂环己酮(PDO)、聚(乙交酯-共-三亚甲基碳酸酯)(PGA-TMC)。可降解材料还包括聚(l-丙交酯-共-乙交酯)(PGA-LPLA)、聚(dl-丙交酯-共-乙交酯)(PGA-DLPLA)、聚(l-丙交酯-共-dl-丙交酯)(LPLA-DLPLA)、聚(乙交酯-共-三亚甲基碳酸酯-共-二氧杂环己酮)(PDO-PGA-TMC)和聚精氨酸中的一种或几种的共聚物。The material of the tissue marking needle is a degradable material, so that the tissue marking needle can be completely degraded in the body, and there is no need to perform an operation again in order to take the tissue marking needle out of the body. It solves the problem in the prior art that the marker needs to be taken out through reoperation. Degradable materials include polylactide (PLA), poly(lactide-co-glycolide) (PLGA), polyanhydrides, polyorthoesters, poly(N-(2-hydroxypropyl)methacrylamide ), poly(dl-lactide) (DLPLA), poly(l-lactide) (LPLA), polyglycolide (PGA), polydioxanone (PDO), poly(glycolide -co-trimethylene carbonate) (PGA-TMC). Degradable materials also include poly(l-lactide-co-glycolide) (PGA-LPLA), poly(dl-lactide-co-glycolide) (PGA-DLPLA), poly(l-lactide-co-glycolide) Lactide-co-dl-lactide) (LPLA-DLPLA), poly(glycolide-co-trimethylene carbonate-co-dioxanone) (PDO-PGA-TMC) and polyfine One or several copolymers of amino acids.
基座10的形状为圆柱体,所述钩体固定设置于所述圆柱体的侧面上。The shape of the base 10 is a cylinder, and the hook is fixedly arranged on the side of the cylinder.
圆柱体的上底面和/或下底面为子弹头形。The upper bottom surface and/or the lower bottom surface of the cylinder is bullet-shaped.
发光涂层为聚((二(对-羧酸苯基)丁二酸酯-共一癸二酸酸酐)(P(p-dCPS:SA))涂层。The luminescent coating is a poly((bis(p-carboxyphenyl)succinate-co-sebacic anhydride) (P(p-dCPS:SA)) coating.
钩体的数量至少为3个。钩体的数量为3个时,3个钩体平均分布在基座外,使组织标记针整体呈鼎状结构,可以将基座牢固地固定在组织上。The number of hook body is at least 3. When the number of hook bodies is 3, the 3 hook bodies are evenly distributed outside the base, so that the tissue marking needle has a tripod-shaped structure as a whole, and the base can be firmly fixed on the tissue.
钩体包括第一钩体110、第二钩体120和第三钩体130。The hook body includes a first hook body 110 , a second hook body 120 and a third hook body 130 .
第一钩体110上设置有第一倒钩1110,所述第二钩体120上设置有第二倒钩1210,所述第三钩体130上设置有第三倒钩1310。倒钩的设置,进一步加强了组织标记针被固定在组织上的稳定性。钩体材料为明胶,明胶在遇水或组织液后会发生膨胀,钩体变大后使基座与组织的连接更加牢固。The first hook body 110 is provided with a first barb 1110 , the second hook body 120 is provided with a second barb 1210 , and the third hook body 130 is provided with a third barb 1310 . The setting of the barb further strengthens the stability that the tissue marking needle is fixed on the tissue. The material of the hook body is gelatin, and the gelatin will swell when exposed to water or interstitial fluid. After the hook body becomes larger, the connection between the base and the tissue becomes stronger.
本例中,钩体为直钩。In this example, the hook body is a straight hook.
实施例2Example 2
本例提供了一种组织标记针,如图1所示,该组织标记针包括This example provides a tissue marking needle, as shown in Figure 1, the tissue marking needle includes
基座10,所述基座10上设置有发光涂层;A base 10, the base 10 is provided with a luminescent coating;
钩体,所述钩体设置于所述基座10外、与所述基座10固定连接。The hook body, the hook body is arranged outside the base 10 and fixedly connected with the base 10 .
本发明实施例的组织标记针,基座上设置有发光涂层,一方面起到标记的作用,可以准确地定位标记活检的组织部位;另一方面也方便再次找到标记处。钩体可以刺入组织中,用于将基座固定在组织上。使用时,通过肠镜的活检孔道,即可便捷地将组织标记针施放到需要标记的组织上,降低了外科医生的操作难度,也减少了患者的痛苦。In the tissue marking needle of the embodiment of the present invention, the base is provided with a luminescent coating, which on the one hand plays the role of marking, and can accurately locate and mark the tissue part of the biopsy; on the other hand, it is also convenient to find the mark again. The hook body can penetrate into the tissue and is used to fix the base on the tissue. When in use, the tissue marking needle can be conveniently placed on the tissue to be marked through the biopsy channel of the colonoscope, which reduces the difficulty of operation for the surgeon and reduces the pain of the patient.
组织标记针的材料为可降解材料,使组织标记针可以在体内完全降解,无须为了将组织标记针从体内取出而再次实施手术。解决了现有技术中,需要通过再次手术将标记物取出的问题。可降解材料包括聚丙交酯(PLA)、聚(丙交酯-共-乙交酯)(PLGA)、聚酐、聚原酸酯、聚(N-(2-羟丙基)甲基丙烯酰胺)、聚(dl-丙交酯)(DLPLA)、聚(l-丙交酯)(LPLA)、聚乙交酯(PGA)、聚二氧杂环己酮(PDO)、聚(乙交酯-共-三亚甲基碳酸酯)(PGA-TMC)。可降解材料还包括聚(l-丙交酯-共-乙交酯)(PGA-LPLA)、聚(dl-丙交酯-共-乙交酯)(PGA-DLPLA)、聚(l-丙交酯-共-dl-丙交酯)(LPLA-DLPLA)、聚(乙交酯-共-三亚甲基碳酸酯-共-二氧杂环己酮)(PDO-PGA-TMC)和聚精氨酸中的一种或几种的共聚物。The material of the tissue marking needle is a degradable material, so that the tissue marking needle can be completely degraded in the body, and there is no need to perform an operation again in order to take the tissue marking needle out of the body. It solves the problem in the prior art that the marker needs to be taken out through reoperation. Degradable materials include polylactide (PLA), poly(lactide-co-glycolide) (PLGA), polyanhydrides, polyorthoesters, poly(N-(2-hydroxypropyl)methacrylamide ), poly(dl-lactide) (DLPLA), poly(l-lactide) (LPLA), polyglycolide (PGA), polydioxanone (PDO), poly(glycolide -co-trimethylene carbonate) (PGA-TMC). Degradable materials also include poly(l-lactide-co-glycolide) (PGA-LPLA), poly(dl-lactide-co-glycolide) (PGA-DLPLA), poly(l-lactide-co-glycolide) Lactide-co-dl-lactide) (LPLA-DLPLA), poly(glycolide-co-trimethylene carbonate-co-dioxanone) (PDO-PGA-TMC) and polyfine One or several copolymers of amino acids.
基座10的形状为圆柱体,所述钩体固定设置于所述圆柱体的侧面上。The shape of the base 10 is a cylinder, and the hook is fixedly arranged on the side of the cylinder.
圆柱体的上底面和/或下底面为子弹头形。The upper bottom surface and/or the lower bottom surface of the cylinder is bullet-shaped.
发光涂层为聚((二(对-羧酸苯基)丁二酸酯-共一癸二酸酸酐)(P(p-dCPS:SA))涂层。The luminescent coating is a poly((bis(p-carboxyphenyl)succinate-co-sebacic anhydride) (P(p-dCPS:SA)) coating.
钩体的数量至少为3个。钩体的数量为3个时,3个钩体平均分布在基座外,使组织标记针整体呈鼎状结构,可以将基座牢固地固定在组织上。The number of hook body is at least 3. When the number of hook bodies is 3, the 3 hook bodies are evenly distributed outside the base, so that the tissue marking needle has a tripod-shaped structure as a whole, and the base can be firmly fixed on the tissue.
钩体包括第一钩体110、第二钩体120和第三钩体130。The hook body includes a first hook body 110 , a second hook body 120 and a third hook body 130 .
第一钩体110上设置有第一倒钩1110,所述第二钩体120上设置有第二倒钩1210,所述第三钩体130上设置有第三倒钩1310。倒钩的设置,进一步加强了组织标记针被固定在组织上的稳定性。钩体材料为明胶,明胶在遇水或组织液后会发生膨胀,钩体变大后使基座与组织的连接更加牢固。The first hook body 110 is provided with a first barb 1110 , the second hook body 120 is provided with a second barb 1210 , and the third hook body 130 is provided with a third barb 1310 . The setting of the barb further strengthens the stability that the tissue marking needle is fixed on the tissue. The material of the hook body is gelatin, and the gelatin will swell when exposed to water or interstitial fluid. After the hook body becomes larger, the connection between the base and the tissue becomes stronger.
本例中,钩体为弯钩。In this example, the hook body is a crotch.
实施例3Example 3
本例提供了组织标记针的使用方法,具体为:This example provides the usage method of the tissue marking needle, specifically:
使用时,通过肠镜的活检孔道,将组织标记针施放到需要标记的组织部位上。During use, the tissue marking needle is applied to the tissue site to be marked through the biopsy channel of the colonoscope.
肠镜的活检孔道为活检取组织、注药和电切除息肉等操作的常用孔道,通过该孔道可以将组织标记针便捷地施放到需要标记的组织部位上。可以直接将组织标记针基座的上底面,即与肠镜的活检孔道相连的一面设计为与活检孔适配的大小,从而便于直接通过活检孔道施放组织标记针。此外,也可以再额外设计一个连接件,该连接件的作用是连接组织标记在的基座和肠镜的活检孔道,便于组织标记针的施放。The biopsy channel of the colonoscope is a common channel for operations such as biopsy tissue collection, drug injection, and electrical resection of polyps. Through this channel, the tissue marking needle can be conveniently placed on the tissue site that needs to be marked. The upper bottom surface of the tissue marking needle base, that is, the side connected to the biopsy channel of the colonoscope, can be directly designed to a size suitable for the biopsy hole, so as to facilitate the application of the tissue marking needle directly through the biopsy channel. In addition, an additional connector can also be designed, and the function of the connector is to connect the base on which the tissue marker is placed and the biopsy channel of the colonoscope, so as to facilitate the deployment of the tissue marker needle.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910916450.8A CN110584796A (en) | 2019-09-26 | 2019-09-26 | Tissue marking needle |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910916450.8A CN110584796A (en) | 2019-09-26 | 2019-09-26 | Tissue marking needle |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110584796A true CN110584796A (en) | 2019-12-20 |
Family
ID=68863659
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910916450.8A Pending CN110584796A (en) | 2019-09-26 | 2019-09-26 | Tissue marking needle |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110584796A (en) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040030262A1 (en) * | 2002-05-03 | 2004-02-12 | Fisher John S. | Biodegradable polymer for marking tissue and sealing tracts |
US20100030149A1 (en) * | 2006-10-23 | 2010-02-04 | C.R. Bard, Inc. | Breast marker |
US20100298698A1 (en) * | 2000-11-20 | 2010-11-25 | Senorx, Inc. | Tissue site markers for in vivo imaging |
CN104736102A (en) * | 2012-05-31 | 2015-06-24 | 标枪医疗有限公司 | Systems, methods and devices for embolic protection |
US9669113B1 (en) * | 1998-12-24 | 2017-06-06 | Devicor Medical Products, Inc. | Device and method for safe location and marking of a biopsy cavity |
CN107072784A (en) * | 2014-06-24 | 2017-08-18 | 中峰医疗公司 | System and method for anchoring implant |
CN211750128U (en) * | 2019-09-26 | 2020-10-27 | 李坚 | Tissue marking needle |
-
2019
- 2019-09-26 CN CN201910916450.8A patent/CN110584796A/en active Pending
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9669113B1 (en) * | 1998-12-24 | 2017-06-06 | Devicor Medical Products, Inc. | Device and method for safe location and marking of a biopsy cavity |
US20100298698A1 (en) * | 2000-11-20 | 2010-11-25 | Senorx, Inc. | Tissue site markers for in vivo imaging |
US20040030262A1 (en) * | 2002-05-03 | 2004-02-12 | Fisher John S. | Biodegradable polymer for marking tissue and sealing tracts |
US20100030149A1 (en) * | 2006-10-23 | 2010-02-04 | C.R. Bard, Inc. | Breast marker |
US20120078238A1 (en) * | 2006-10-23 | 2012-03-29 | C. R. Bard, Inc. | Breast marker |
CN104736102A (en) * | 2012-05-31 | 2015-06-24 | 标枪医疗有限公司 | Systems, methods and devices for embolic protection |
CN107072784A (en) * | 2014-06-24 | 2017-08-18 | 中峰医疗公司 | System and method for anchoring implant |
CN211750128U (en) * | 2019-09-26 | 2020-10-27 | 李坚 | Tissue marking needle |
Non-Patent Citations (2)
Title |
---|
樊军: "新型荧光聚酸酐的合成、表征及其性能研究", 《浙江大学博士学位论文》, 15 February 2007 (2007-02-15), pages 50 - 76 * |
胡志刚: "荧光共聚酸酐纳米粒子的制备及其药物控释和细胞成像领域中的应用", 浙江大学硕士论文, 15 October 2012 (2012-10-15), pages 19 - 27 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4472176B2 (en) | Biopsy position confirmation method and instrument | |
US7127040B2 (en) | Device and method for margin marking tissue to be radiographed | |
US5941890A (en) | Implantable surgical marker | |
US7881775B2 (en) | Radio guided seed localization of imaged lesions | |
CA2490066C (en) | Plugged tip delivery tube for marker placement | |
US20060258933A1 (en) | Method of defining a biological target for treatment | |
US10238464B2 (en) | Target identification tool for intra-body localization | |
US20070038014A1 (en) | Radio guided seed localization of imaged lesions | |
US20090171198A1 (en) | Powdered marker | |
US20080294039A1 (en) | Assembly with hemostatic and radiographically detectable pellets | |
US20090131825A1 (en) | Imageable biopsy site marker | |
JP5866459B2 (en) | Biopsy grid | |
EP1301125A2 (en) | Bioabsorbable markers for use in biopsy procedures | |
CN211750128U (en) | Tissue marking needle | |
CN110584796A (en) | Tissue marking needle | |
CN111407395B (en) | Positioning system and method of use | |
US20200276451A1 (en) | Needle guidance device for brachytherapy and method of use | |
CN208319695U (en) | Multifunctional guide template with fluorescence coordinate system |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20200714 Address after: 410008 No. 503, Building 24, 110 Xiangya Road, Kaifu District, Changsha City, Hunan Province Applicant after: Li Jian Address before: 410008 Hunan province Changsha Kaifu District, Xiangya Road No. 87 Applicant before: XIANGYA HOSPITAL OF CENTRAL SOUTH University |
|
TA01 | Transfer of patent application right |